However, as noted previously [24]–[26], in Barrett's esophagus with dysplasia and in esophageal adenocarcinoma, the percent of Cdx2 positive cells declined in most samples, but was persistent in others (Figure 5F, 5H, 5I). Here, CDX2 is linked to esophageal adenocarcinoma.